Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Une voix s’est éteinte.
Teillaud JL. Teillaud JL. Med Sci (Paris). 2021 Dec;37 Hors série n° 2:15-16. doi: 10.1051/medsci/2021218. Epub 2021 Dec 13. Med Sci (Paris). 2021. PMID: 34895452 Free article. French. No abstract available.
HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI, Aris M, Panouillot M, Porto M, Dieu-Nosjean MC, Teillaud JL, Barrio MM, Mordoh J. Bravo AI, et al. Among authors: teillaud jl. Front Immunol. 2023 Aug 25;14:1231734. doi: 10.3389/fimmu.2023.1231734. eCollection 2023. Front Immunol. 2023. PMID: 37691949 Free PMC article.
Defining biomarkers in oral cancer according to smoking and drinking status.
Rochefort J, Karagiannidis I, Baillou C, Belin L, Guillot-Delost M, Macedo R, Le Moignic A, Mateo V, Soussan P, Brocheriou I, Teillaud JL, Dieu-Nosjean MC, Bertolus C, Lemoine FM, Lescaille G. Rochefort J, et al. Among authors: teillaud jl. Front Oncol. 2023 Jan 11;12:1068979. doi: 10.3389/fonc.2022.1068979. eCollection 2022. Front Oncol. 2023. PMID: 36713516 Free PMC article.
Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy.
Casadesús AV, Cruz BM, Díaz W, González MÁ, Gómez T, Fernández B, González A, Ledón N, Sosa K, Castro K, López A, Plasencia C, Ramírez Y, Teillaud JL, Hernández C, León K, Hernández T. Casadesús AV, et al. Among authors: teillaud jl. Front Immunol. 2022 Dec 9;13:1021828. doi: 10.3389/fimmu.2022.1021828. eCollection 2022. Front Immunol. 2022. PMID: 36569901 Free PMC article.
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma.
Kassem S, Diallo BK, El-Murr N, Carrié N, Tang A, Fournier A, Bonnevaux H, Nicolazzi C, Cuisinier M, Arnould I, Sidhu SS, Corre J, Avet-Loiseau H, Teillaud JL, van de Velde H, Wiederschain D, Chiron M, Martinet L, Virone-Oddos A. Kassem S, et al. Among authors: teillaud jl. Blood. 2022 Feb 24;139(8):1160-1176. doi: 10.1182/blood.2021012448. Blood. 2022. PMID: 35201323 Free article.
177 results